rxstat › Shortages › Iohexol

Iohexol (Omnipaque) shortage status

No current shortage

Source: Health Canada shortage reports · Updated Oct 28, 2026

Iohexol has no current shortage reported in Canada. It has been in shortage before; the history is below.

An iodinated contrast agent used to improve the clarity of X-ray and CT scans.

Products affected
0 / 4
Reports on file
55

Shortage history

2023 2024 2025 2026

Shortage history (red bands = periods in shortage).

Reports by product

The DIN is printed on your prescription label.

Resolved
OMNIPAQUE 240
518MG · SOLUTION · GE HEALTHCARE CANADA INC
DIN 02172739 · ended Oct 28, 2026 · Delay in manufacturing
Resolved
OMNIPAQUE 240
518MG · SOLUTION · GE HEALTHCARE CANADA INC
DIN 02172739 · ended Oct 5, 2026 · Production Delay
Resolved
OMNIPAQUE 240
518MG · SOLUTION · GE HEALTHCARE CANADA INC
DIN 02172739 · ended Aug 20, 2026 · Production Delay
Resolved
OMNIPAQUE 240
518MG · SOLUTION · GE HEALTHCARE CANADA INC
DIN 02172739 · ended Jun 6, 2025 · Demand increase for the drug.
Resolved
OMNIPAQUE 240
518MG · SOLUTION · GE HEALTHCARE CANADA INC
DIN 02172739 · ended May 23, 2025 · Demand increase for the drug.
Resolved
OMNIPAQUE 350
755MG · SOLUTION · GE HEALTHCARE CANADA INC
DIN 02172755 · ended May 2, 2025 · Reason for shortage - manufacturing delay
Resolved
OMNIPAQUE 350
755MG · SOLUTION · GE HEALTHCARE CANADA INC
DIN 02172755 · ended Apr 28, 2025 · Delay in shipping of the drug.
Resolved
OMNIPAQUE 300
647MG · SOLUTION · GE HEALTHCARE CANADA INC
DIN 02172747 · ended Apr 21, 2025 · Delay in shipping of the drug.
Resolved
OMNIPAQUE 240
518MG · SOLUTION · GE HEALTHCARE CANADA INC
DIN 02172739 · ended Mar 3, 2025 · Reason for shortage: production release delay. A substitute of same concentration but at a different volume will be offered as an alternative.
Resolved
OMNIPAQUE 240
518MG · SOLUTION · GE HEALTHCARE CANADA INC
DIN 02172739 · ended Sep 27, 2024 · Demand increase for the drug.
Resolved
OMNIPAQUE 240
518MG · SOLUTION · GE HEALTHCARE CANADA INC
DIN 02172739 · ended Sep 20, 2024 · Demand increase for the drug.
Resolved
OMNIPAQUE 240
518MG · SOLUTION · GE HEALTHCARE CANADA INC
DIN 02172739 · ended Jun 11, 2024 · Demand increase for the drug.

Showing 12 of 55 reports. All reports are on file with Health Canada.

What's happening

There are no active shortage reports for Iohexol. Health Canada has 55 historical reports on file for this drug, so supply has been disrupted before; the change log below shows the history.

Iohexol is classified under “X-RAY CONTRAST MEDIA, IODINATED” (ATC V08AB).

Recent changes

Common questions

What is Iohexol used for?

An iodinated contrast agent used to improve the clarity of X-ray and CT scans.

When will Iohexol be back in stock in Canada?

Iohexol has no active shortage; supply is normal per Health Canada reports.

Why is Iohexol in shortage?

It isn't currently. Past reports and their reasons are listed above.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Related drugs (x-ray contrast media, iodinated)

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.